GlassScriptPhysician profile
Daniel Colon-Conde
NPI 1962898031
$5,291.29
in general payments reported to CMS, 2019-2025
18 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $416 · 2022: $3,120 · 2023: $799 · 2024: $698 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,754.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,991.57 | 2021-2024 | Intellis Adaptivestim, Accurian, Synchromedii |
| Boston Scientific Corporation | $982.60 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $386.56 | 2021-2025 | Belbuca, Xtampza |
| Nevro Corp. | $378.85 | 2022-2023 | Senza |
| Stimwave Technologies Incorporated | $271.92 | 2021-2022 | |
| Curonix LLC | $246.16 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $172.80 | 2022-2023 | Ztlido |
| Forte Bio-Pharma LLC | $171.52 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $158.22 | 2022-2025 | Relistor |
| Stryker Corporation | $150.00 | 2024 | Mild Device Kit |
| Trevena, INC. | $110.45 | 2022-2023 | Olinvyk |
| Averitas Pharma INC. | $77.13 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $56.67 | 2022 | |
| Tersera Therapeutics LLC | $38.75 | 2022-2023 | Prialt |
| Foundation Fusion Solutions, LLC | $32.74 | 2024-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $26.51 | 2025 | |
| Biodelivery Sciences International, INC. | $23.04 | 2021 | |
| Azurity Pharmaceuticals, INC. | $15.80 | 2023 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Colon-Conde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.